Dr. Cohen is being recognized for his basic and translational liver disease research. For 30 years, he has researched non-alcoholic fatty liver disease.
“I am both honored to be the recipient of this award and humbled to be listed among its prior recipients, many of whom have been important role models and mentors for me over the course of my career,” Dr. Cohen said in a Nov. 7 press release. “And I am particularly grateful to the American Liver Foundation for its many years of passionate support of research aimed at the causes and cures for liver disease, including my own, as well as patient advocacy and education.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
